$107,530,978

Department of Health and Human Services·National Institutes of Health

to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

ACTION DATE2026-03-19·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75N93019C00051_7529_-NONE-_-NONE-

Award description

THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Support research to design and evaluate innovative influenza vaccine approaches based on immunity principles for durable protection.

Sub-sectors

vaccine-developmentinfluenza-vaccinesnih-research-grant

Why this matters

Influenza vaccine innovation is critical for pandemic preparedness and reducing seasonal flu burden affecting millions annually.

Supply-chain signal

Signals demand for advanced vaccine manufacturing platforms, adjuvants, and clinical trial infrastructure from biotech suppliers.

U.S.–China competition angle

U.S. investment in next-generation flu vaccines counters China's vaccine development capabilities and global health influence.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002169.

Period of performance

Start

2019-09-10

End

2027-02-28

Status

activein 288 days

Recipient

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

UEI C8H9CNG1VBD9

View full profile →

Other awards from this recipient

See all →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75N93019C00051_7529_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.